P
Patrícia O. Guimarães
Researcher at University of São Paulo
Publications - 8
Citations - 432
Patrícia O. Guimarães is an academic researcher from University of São Paulo. The author has contributed to research in topics: Aspirin & Coronary artery disease. The author has an hindex of 3, co-authored 8 publications receiving 104 citations. Previous affiliations of Patrícia O. Guimarães include Albert Einstein Hospital.
Papers
More filters
Journal ArticleDOI
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
Patrícia O. Guimarães,Daniel Quirk,Remo H. Furtado,Lilia N. Maia,José F. Saraiva,Murillo Oliveira Antunes,Roberto Kalil Filho,Vagner Madrini Junior,Alexandre de Matos Soeiro,Alexandre P. Tognon,Viviane C Veiga,Priscilla de Aquino Martins,Diogo D.F. Moia,Bruna S. Sampaio,Silvia R.L. Assis,Ronaldo V P Soares,Luciana P.A. Piano,Kleber Castilho,Roberta G.R.A.P. Momesso,Frederico Monfardini,Hélio Penna Guimarães,Dario Ponce de Leon,Majori Dulcine,Marcia Pinheiro,Levent M. Gunay,J. Jasper Deuring,Luiz Vicente Rizzo,Tamas Koncz,Otavio Berwanger +28 more
TL;DR: Among patients hospitalized with Covid-19 pneumonia, tofacitinib led to a lower risk of death or respiratory failure through day 28 than placebo, and the proportional odds of having a worse score on the eight-level ordinal scale with tofacinib, as compared with placebo.
Journal ArticleDOI
Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study.
Norihiro Kogame,Norihiro Kogame,Patrícia O. Guimarães,Rodrigo Modolo,Fernando de Martino,João Eduardo Prudêncio Tinoco,Expedito E. Ribeiro,Hideyuki Kawashima,Masafumi Ono,Hironori Hara,Rutao Wang,Rafael Cavalcante,Bruno Moulin,Breno de Alencar Araripe Falcão,Rogério S. Leite,Fernanda Barbosa de Almeida Sampaio,Gustavo R. Morais,George C. Meireles,Carlos M. Campos,Yoshinobu Onuma,Patrick W. Serruys,Patrick W. Serruys,Pedro A. Lemos +22 more
TL;DR: Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent implantation demonstrated feasibility and safety without any stent thrombosis in selected low-risk patients with stable CAD.
Journal ArticleDOI
Association between perivascular inflammation and downstream myocardial perfusion in patients with suspected coronary artery disease
Cesar Higa Nomura,Antonildes N Assuncao-Jr,Patrícia O. Guimarães,Gabriela Liberato,Thamara C Morais,Mateus G Fahel,Maria Clementina Pinto Giorgi,José Cláudio Meneghetti,José R. Parga,Roberto Nery Dantas-Jr,Giovanni Guido Cerri +10 more
TL;DR: Coronary perivascular inflammation by CTA was independently associated with downstream myocardial perfusion by PET and in patients with low CCS or without obstructive CAD, CFR was lower in the presence of higher periv vascular inflammation.
Journal ArticleDOI
Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.
Alexandre Abizaid,Carlos M. Campos,Patrícia O. Guimarães,Jose de Ribamar Costa,Breno de Alencar Araripe Falcão,Fernanda Mangione,Adriano Caixeta,Pedro A. Lemos,Fabio Sandoli de Brito,Ricardo Cavalcante,Cristiano Guedes Bezerra,Leandro A Côrtes,Henrique Barbosa Ribeiro,Francis R. de Souza,Natassja Huemer,Renata do Val,Bruno Caramelli,Daniela Calderaro,Felipe G. Lima,Ludhmila Abrahão Hajjar,Roxana Mehran,Roberto Kalil Filho +21 more
TL;DR: In this paper, the authors explore angiographic patterns and in-hospital outcomes of patients with concomitant coronavirus disease-19 (COVID-19) and myocardial infarction (MI).
Journal ArticleDOI
Câncer e Doenças Cardiovasculares na Pandemia de COVID-19
Lucas Tokio Kawahara,Isabela Bispo Santos da Silva Costa,Cecília Chie Sakaguchi Barros,Gabriel Coelho de Almeida,Cristina Salvadori Bittar,Stephanie Itala Rizk,Laura Testa,Camila Motta Venchiarutti Moniz,Juliana Pereira,Gláucia Maria Moraes de Oliveira,Maria Del Pilar Estevez Diz,Patrícia O. Guimarães,Ibraim Pinto,Roberto Kalil Filho,Ludhmila Abrahão Hajjar,Paulo M. Hoff +15 more
TL;DR: Cardio-oncology has gained a new dimension, with the aim of adapting to patients' needs during the pandemic by restructuring the system of care in a manner that offers quality and safety in healthcare.